PedAM
Pediatric Disease Annotations & Medicines
| Disease | hyperandrogenism |
| Phenotype | C0003128|anovulation |
| Sentences | 6 |
| PubMedID- 24746168 | Polycystic ovary syndrome (pcos) is characterized by chronic anovulation (failure or absence of ovulation) and hyperandrogenism (excessive production of male hormones in women) with clinical manifestations of irregular menstrual cycles, infertility, hirsutism, and acne [1], which is a common condition affecting women of reproductive age in 5 to 10% [2]. |
| PubMedID- 26261426 | Recent literature have found that greater adiposity was described in more severe reproductive phenotypes (characterized by hyperandrogenism associated with chronic anovulation),49 and lean women had milder reproductive phenotype compared with those who were overweight;97 so obesity can exacerbate the pcos reproductive phenotypes. |
| PubMedID- 20816585 | Polycystic ovary syndrome (pcos) is characterized by laboratory and/or clinical features consisting of hyperandrogenism with chronic anovulation and is currently one of the most common endocrinopathies in women of fertile age. |
| PubMedID- 20578591 | Polycystic ovary syndrome (pcos) is characterized by laboratory or clinical signs of hyperandrogenism with chronic anovulation and is currently one of the most frequent endocrinopaties in women of fertile age. |
| PubMedID- 22223701 | The pcos women were classified into three groups: group a presented biochemical hyperandrogenism, combined with anovulation and polycystic ovarian morphology; group b, clinical hyperandrogenism combined with anovulation and polycystic ovarian morphology; and group c, chronic anovulation and polycystic ovarian morphology. |
| PubMedID- 25006718 | The polycystic ovary syndrome was defined according to modified rotterdam criteria (anovulation with either hyperandrogenism or polycystic ovaries). |
Page: 1